Excessive circulating FGF23 acts as a phosphaturic hormone, inducing renalphosphate wasting and inhibiting an appropriate increase in circulating calcitriol,which ultimately leads to hypophosphatemia.1,2 Chronic hypophosphatemia resultsin inadequate bone mineralization and presents clinically as osteomalacia. This evidence concerns the gene FGF23 and osteomalacia.